Video is loading...
Title: Targeted Therapy Promising For Cancer Patients - CNL
Summary: Patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor’s molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
Keywords: Metastatic, melanoma, phase 1, clinical trial, targeted therapy, tumor, cancer, Cancer Newsline, Cancerwise